Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rizatriptan in treatment of postictal headache
IRCT20210908052414N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rizatriptan in Postictal Headache (PIH), sponsored by Shiraz University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
rizatriptan
03
Conditions
Postictal Headache (PIH)
Beyond the preview
Go deeper on IRCT20210908052414N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210908052414N1.